估计供股所得款项净额约为3.24亿港元，68%用于全数偿还应付MIC的借款本金，22%用于拨付K&S的 采矿业务，10%用于补充一般营运资金。 智通财经APP讯，铁货(01029)公布，公司建议按非全数包销基准，按"2供1"基准发行最多约6.39亿股供 股股份，每股供股股份0.51港元，较较股份于最后交易日在联交所所报的收市价每股0.610港元折让约 16.39%，借此筹集最多约3.26亿港元。 ...

鳄鱼恤(00122)公布，公司建议以供股方式，按"2供1"基准向合资格股东发行最多约3553.29万股供股股 份(假设已发行股份数目于记录日期或之前概无变动)，每股供股股份1.50港元，较股份于最后交易日在 联交所所报的收市价每股1.94港元折让约22.68%，借此筹集最多约5329.93万港元(扣除开支前)。 假设所有供股股份获承购，供股净筹约5160万港元，拟用于偿还集团的银行借款及偿付利息。 ...

Core Viewpoint - The company, Xie Tong Communication, proposes to raise up to approximately HKD 121 million through a rights issue, offering eligible shareholders the opportunity to subscribe for new shares at a price of HKD 0.135 per share [1] Group 1: Rights Issue Details - The rights issue is structured such that for every share held, eligible shareholders can subscribe for 2 new shares, totaling 897 million shares to be issued [1] - Upon completion of the rights issue, the new shares will represent 200% of the company's existing share capital as of the announcement date, and approximately 66.67% of the enlarged share capital [1] Group 2: Use of Proceeds - The net proceeds from the rights issue, estimated to be around HKD 119 million after expenses, will be allocated as follows: approximately 74.9% for identified needs in expanding the group's control systems and building intelligence businesses, and about 25.1% for general working capital and corporate purposes [1]

Core Viewpoint - The company,协同通信(01613), plans to raise approximately HKD 121 million through a rights issue, offering eligible shareholders two new shares for every existing share held at a subscription price of HKD 0.135 per share [1] Group 1: Rights Issue Details - The rights issue will involve the issuance of 897 million new shares, which represents 200% of the company's existing share capital as of the announcement date [1] - If the rights issue is fully subscribed, the estimated net proceeds after expenses will be approximately HKD 119 million [1] Group 2: Use of Proceeds - Approximately 74.9% or about HKD 89.3 million of the net proceeds will be allocated to meet the identified genuine needs for expanding the group's control systems and building intelligence businesses [1] - The remaining 25.1% or about HKD 30 million will be used for general working capital and corporate purposes [1]

格隆汇10月9日丨万马控股(06928.HK)公告，内容有关按于记录日每持有2股份获发1股供股股份之基准 进行供股。于2025年9月15日(星期一)下午四时正，即最后有接纳时限，公司已接获合共5份有效申请及 接纳，涉及供股项下暂定配发合共1.4亿股供股股份(相当于供股项下发售之供股股份总数约63.43%)。因 此，供股约有63.43%已获认购，而未获认购股份为8228万股，相当于供股项下发售之供股股份总数约 36.57%，将根据补偿安排处理。 董事会谨此宣布，于2025年9月29日(星期一)下午四时正，即配售代理配售未获认购股份的最后时限， 8228万股未获认购股份已全部根据配售按每股股份0.18港元(相等于认购价)成功配售。因此，根据补偿 安排并无可供分配予不行动股东或除外股东的净收益。根据供股的接纳结果及补偿安排的配售结果，将 予配发及发行的供股股份为2.25亿股供股股份，占供股项下提呈认购的供股股份总数100%。 由于供股章程所载有关供股的所有条件均已获达成，供股于2025年9月30日(星期二)成为无条件。因 此，供股(包括补偿安排)所得款项总额约为4050万港元，供股所得款项净额(经扣除所有相关开支后 ...

永泰生物-B(06978)发布公告，董事会建议按认购价每股供股股份2.5港元，基准为于记录日期每持有5股 现有已发行股份获发1股供股股份，向合资格股东发行最多1.03亿股供股股份(假设于记录日期或之前并 无发行或购回新股份)或1.23亿股供股股份(假设于记录日期或之前可换股债券获悉数转换及购股权获行 使)，以分别筹集最多达2.57亿港元或3.08亿港元的所得款项总额。 公司拟按以下方式运用供股所得款项净额：约54%用作EAL临床试验;约24%用作扩大EAL其他临床适应 症的研发开支;及约22%用作集团一般营运资金。 此外，公司已向香港联合交易所有限公司申请于2025年9月22日上午九时正起恢复股份交易。 ...

Group 1 - The core point of the article is that Xinjiang Xintai Natural Gas Co., Ltd.'s overseas subsidiary, Zhongneng Holdings (00228.HK), plans to implement a capital restructuring and rights issue [1] - The capital restructuring includes share consolidation, capital reduction, and share split, which will not involve any cash transactions and will not change the equity structure or financial status [1] - The rights issue will be conducted at a ratio of 1 share for every 2 shares held, with a subscription price of HKD 1.57 per share, aiming to raise approximately HKD 239 million for expenses related to the Kashgar North project [1]

Core Viewpoint - Dayu Financial plans to raise a total of approximately HKD 136.7 million through a rights issue, offering shares at HKD 0.12 each [1] Group 1 - The company proposes to issue up to 1.139 billion rights shares at a ratio of 1 share for every 2 existing shares held by eligible shareholders [1] - The estimated net proceeds from the fundraising are approximately HKD 136.1 million [1] - Approximately HKD 116.1 million of the proceeds will be allocated to the group's margin financing business, while HKD 20 million will be used for general working capital [1]